AKT1 and cholangiocarcinoma: Since Akt signaling plays a key role in cancer cell proliferation and antiapoptosis, it is reasonable to suggest that mTOR-Akt negative feedback might play an essential role in suppressing the antitumor efficacy of rapamycin in CCA.